Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,402 | 382 | 99.4% |
| Education | $45.13 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $801.99 | 47 | $0 (2024) |
| Allergan, Inc. | $728.40 | 42 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $622.56 | 31 | $0 (2023) |
| ABBVIE INC. | $563.91 | 25 | $0 (2023) |
| ITI, Inc. | $558.24 | 27 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $536.76 | 24 | $0 (2023) |
| Alkermes, Inc. | $529.26 | 26 | $0 (2023) |
| Lundbeck LLC | $415.98 | 20 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $410.64 | 27 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $402.37 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.71 | 3 | Almatica Pharma LLC ($29.88) |
| 2023 | $1,366 | 58 | ABBVIE INC. ($260.82) |
| 2022 | $1,707 | 97 | ITI, Inc. ($367.76) |
| 2021 | $1,125 | 58 | AbbVie Inc. ($208.28) |
| 2020 | $483.72 | 24 | Otsuka America Pharmaceutical, Inc. ($154.01) |
| 2019 | $994.33 | 61 | Allergan Inc. ($300.55) |
| 2018 | $587.29 | 31 | Vanda Pharmaceuticals Inc. ($115.12) |
| 2017 | $1,130 | 53 | Allergan Inc. ($259.36) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ANTI-ANXIETY | ||||||
| 02/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Neurology | ||||||
| 01/02/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/21/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.30 | General |
| 12/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Neurology | ||||||
| 11/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/10/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Neurology | ||||||
| 10/30/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: ADHD | ||||||
| 10/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/10/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: ADHD | ||||||
| 09/14/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: ANTI-ANXIETY | ||||||
| 09/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Neurology | ||||||
| 08/31/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 162 | $25,240 | $17,153 |
| 2022 | 4 | 118 | 351 | $57,375 | $28,189 |
| 2021 | 4 | 142 | 489 | $80,575 | $40,045 |
| 2020 | 4 | 156 | 562 | $81,600 | $44,609 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 140 | $18,200 | $13,957 | 76.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $7,040 | $3,197 | 45.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 91 | $13,650 | $7,876 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 121 | $15,125 | $7,851 | 51.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 28 | 107 | $21,400 | $7,100 | 33.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $7,200 | $5,362 | 74.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 173 | $21,650 | $11,992 | 55.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 33 | 163 | $32,200 | $11,133 | 34.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 112 | $16,800 | $9,896 | 58.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 41 | $9,925 | $7,024 | 70.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 162 | $24,300 | $14,582 | 60.0% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 39 | 179 | $26,850 | $12,743 | 47.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 181 | $21,450 | $10,300 | 48.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 40 | 40 | $9,000 | $6,985 | 77.6% |
About Dr. Won Lee, MD
Dr. Won Lee, MD is a Psychiatry healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336106921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Won Lee, MD has received a total of $7,447 in payments from pharmaceutical and medical device companies, with $52.71 received in 2024. These payments were reported across 385 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,402).
As a Medicare-enrolled provider, Lee has provided services to 463 Medicare beneficiaries, totaling 1,564 services with total Medicare billing of $129,997. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Geriatric Psychiatry
- Location Long Beach, CA
- Active Since 04/27/2006
- Last Updated 09/12/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336106921
Products in Payments
- VRAYLAR (Drug) $1,292
- REXULTI (Drug) $724.17
- AUSTEDO (Drug) $718.22
- CAPLYTA (Drug) $558.24
- ARISTADA (Drug) $496.15
- LATUDA (Drug) $410.64
- SPRAVATO (Drug) $326.74
- INGREZZA (Drug) $323.12
- TRINTELLIX (Drug) $201.91
- Auvelity (Drug) $196.76
- Fanapt (Drug) $190.02
- HETLIOZ (Drug) $178.96
- Trintellix (Drug) $157.68
- ADHANSIA XR (Drug) $134.93
- QELBREE (Drug) $128.33
- INVEGA SUSTENNA (Drug) $123.56
- Adzenys XR-ODT (Drug) $109.04
- Dyanavel XR (Drug) $102.46
- ABILIFY MAINTENA (Drug) $94.35
- ABILIFY MYCITE (Drug) $91.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Long Beach
Dr. Armen Goenjian, Md, MD
Psychiatry — Payments: $187,424
Dr. Haig Goenjian, Md, MD
Psychiatry — Payments: $23,747
Dr. Jay Lentzner, M.d, M.D
Psychiatry — Payments: $19,525
Dharmesh Sheth, Md, MD
Psychiatry — Payments: $16,939
Dr. James Jen Kin, Md, MD
Psychiatry — Payments: $16,619
Dr. Christopher Reist, Md, MD
Psychiatry — Payments: $13,323